Rigel Pharmaceuticals Inc. (RIGL) released earnings for its fourth quarter that increased from the same period last year
The company's bottom line came in at $14.34 million, or $0.80 per share. This compares with $0.74 million, or $0.04 per share, last year.
The company's revenue for the period rose 60.9% to $57.60 million from $35.79 million last year.
Rigel Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings: $14.34 Mln. vs. $0.74 Mln. last year.
-EPS: $0.80 vs. $0.04 last year.
-Revenue: $57.60 Mln vs. $35.79 Mln last year.
For comments and feedback: editorial@rttnews.com